Introduction: ADP plays a key role in regulating platelet function by activation of P2Y 1 and P2Y 12 G protein-coupled receptors (GPCRs). We have recently shown in a patient with mild bleeding that the PDZ-binding motif of the P2Y 12 receptor (P2Y 12 R) is required for effective receptor traffic in human platelets (Nisar et al., 2011) . For other GPCRs this motif is required for efficient receptor traffic via interaction with the PDZ-binding domain containing Na + /H + Exchanger Regulatory Factors (NHERFs). Here we investigated the role of NHERF1 in P2Y 12 R regulation. Methods: HA-tagged P2Y 12 R expressed in human 1321N1 astrocytoma cells and human platelets were both used in these studies. Protein interactions were investigated by co-immunoprecipitation and immunoblotting. Trafficking was studied using ELISA and confocal microscopy, to quantify and visualise receptor trafficking, respectively. Results: Endogenous P2Y 12 R co-localised with NHERF1 in human platelets upon ADP stimulation. In addition the C-tail of the P2Y 12 R bound NHERF1 in platelet cell lysates. In 1321N1 cells P2Y 12 R interacted with NHERF1 in an agonist-dependent manner whilst siRNA knockdown of NHERF1 blocked P2Y 12 R internalisation (loss of surface receptor was 20.5±1.3% versus 5.4 ±1.9% following ADP treatment (10 µM; 30 min) in scrambled and NHERF1 siRNA knockdown cells respectively) but did not affect acute receptor signalling or desensitization. Interestingly removal of the PDZ-binding motif of the P2Y 12 R which reduces receptor internalization reduced agonist-independent NHERF1 / P2Y 12 R interaction but did not abolish agonist-dependent NHERF1 interaction. siRNA knockdown of β-arrestins which are also required for P2Y 12 R internalization (Mundell et al., 2006) did however reduce P2Y 12 R/NHERF1 interaction. Further studies demonstrated that NHERF1 and β-arrestin are able to interact in cell lines and importantly P2Y 12 R activation increases the level of this interaction. Conclusions: We report for the first time a novel interaction between NHERF1 and P2Y 12 and between NHERF1 and β-arrestin. This study is the first demonstration that NHERF proteins are required for agonist-dependent GPCR internalisation. Our data allow us to propose the following novel model of P2Y 12 R internalization. Prior to agonist stimulation there is a basal association between the P2Y 12 R and NHERF1 that requires the PDZ binding motif of this receptor. On receptor stimulation NHERF1 no longer directly interacts with the receptor but instead binds via β-arrestin where it plays an essential role in regulating receptor internalization. This study therefore suggests that arrestin can serve as an adaptor to promote NHERF1 interaction with a GPCR in order to facilitate effective NHERF1-dependent receptor internalization.
